Dr. Kelty R. Baker, MD
Hematology (Hematology (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- Baylor College of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 533
Licensed in Texas since 1994, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Baylor College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology (Internal Medicine) Physician primary
TX license J6316 (first issued 1994; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Houston Methodist Hospital Houston, TX
- Houston Methodist Sugarland Hospital Sugar Land, TX
- Houston Methodist the Woodlands Hospital The Woodlands, TX
- Houston Methodist West Hospital Houston, TX
- Houston Methodist Clear Lake Hospital Nassau Bay, TX
Medical groups
- Kelty R Baker M D P A (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 533
- Services billed
- 2,757
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 939 | 411 |
| Established patient office or other outpatient visit, 30-39 minutes | 565 | 331 |
| Established patient office or other outpatient visit, 40-54 minutes | 266 | 122 |
| Established patient office or other outpatient visit, 20-29 minutes | 145 | 121 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 115 | 42 |
| New patient office or other outpatient visit, 60-74 minutes | 63 | 63 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 41 | 23 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 34 | 12 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 20 | 20 |
| New patient office or other outpatient visit, 45-59 minutes | 17 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Houston, TX | 71 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Houston, TX | 51 |
| Jakafi (ruxolitinib phosphate) | 44 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Houston, TX | 39 |
| Xarelto (rivaroxaban) Other prescribers in Houston, TX | 39 |
| Levothyroxine Sodium Other prescribers in Houston, TX | 22 |
| Ojjaara (momelotinib dihydrochloride) | 21 |
| Hydromorphone Hcl Other prescribers in Houston, TX | 20 |
| Hydroxyurea Other prescribers in Houston, TX | 20 |
| Promacta (eltrombopag olamine) | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 50 payments worth $7,844 in total to this clinician.
| Genzyme Corporation | $3,281 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $1,991 |
| Incyte Corporation | $1,237 |
| E.r. Squibb & Sons, L.l.c. | $455 |
| Pfizer Inc. | $302 |
| Celgene Corporation | $130 |
| Recordati_rare_diseases_inc. | $125 |
| Sobi, Inc | $55.90 |
| Consulting Fee | $4,579 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $1,960 |
| Food and Beverage | $1,266 |
| Education | $32.41 |
| Travel and Lodging | $7.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Apr 15, 2025 | Consulting Fee | $3,024 |
| AstraZeneca Pharmaceuticals LP Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) CALQUENCE · Oncology Company’s descriptionSpeaker Fee | $1,960 |
| Incyte Corporation Jun 18, 2025 | Consulting Fee | $1,100 |
| E.r. Squibb & Sons, L.l.c. May 15, 2025 | Consulting Fee | $455 |
| Pfizer Inc. Mar 19, 2025 | Education ELREXFIO · ONCOLOGY · in-kind | $17.16 |
| Beone Medicines USA, Inc. May 16, 2025 | Education BRUKINSA · Oncology · in-kind | $15.25 |
| Genzyme Corporation Apr 15, 2025 | Travel and Lodging travel to Houston, TX | $7.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.